Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Xu

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 17, 2017
[Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation]Y R Ma, X J Huang, X D Mo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 27, 2025
[Allogeneic hematopoietic stem cell transplantation for the treatment of BCR::ABL-negative neutrophilic myeloid neoplasms: a clinical analysis of 12 cases]T T Han, Y He, J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 15, 2021
[Comparison of prognostic significance between multiparameter flow cytometry and real-time quantitative polymerase chain reaction in the detection of minimal residual disease of Philadelphia chromosome-positive acute B lymphocytic leukemia before allogeneic hematopoietic stem cell transplantation]X Y Wang, Y J Chang, Y R Liu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 25, 2016
Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatmentsX-D Mo, X-H Zhang, L-P Xu, et al.
Bone Marrow Transplantation|November 8, 2011
Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysisY Wang, D-H Liu, L-P Xu, et al.
Bone Marrow Transplantation|January 21, 2014
Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinibX-D Mo, Q Jiang, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 16, 2024
[Clinical analysis of allogeneic hematopoietic cell transplantation in 9 patients with hematological malignancies complicated by Gilbert's syndrome]X L Zhu, J Z Wang, M Lyu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 2, 2025
[Clinical characteristics of HHV-6 infection after allogeneic hematopoietic stem cell transplantation]L Huang, T T Han, F F Wei, et al.
Zhonghua Yi Xue Za Zhi|August 25, 2025
[Clinical characteristics and outcomes of invasive mucormycosis after allogeneic hematopoietic stem cell transplantation]C Li, R Ma, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 4, 2024
[Rituximab based treatment in pediatric Epsstain Bar Virus associated lymphocyte proliferative diseases after aplastic anemia with haplo-identical transplantation:a prospective single centre study]F Zhang, G H Hu, P Suo, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 17, 2017
[Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation]Y R Ma, X J Huang, X D Mo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 27, 2025
[Allogeneic hematopoietic stem cell transplantation for the treatment of BCR::ABL-negative neutrophilic myeloid neoplasms: a clinical analysis of 12 cases]T T Han, Y He, J Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 15, 2021
[Comparison of prognostic significance between multiparameter flow cytometry and real-time quantitative polymerase chain reaction in the detection of minimal residual disease of Philadelphia chromosome-positive acute B lymphocytic leukemia before allogeneic hematopoietic stem cell transplantation]X Y Wang, Y J Chang, Y R Liu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 25, 2016
Late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation: prognostic factors and treatmentsX-D Mo, X-H Zhang, L-P Xu, et al.
Bone Marrow Transplantation|November 8, 2011
Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysisY Wang, D-H Liu, L-P Xu, et al.
Bone Marrow Transplantation|January 21, 2014
Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinibX-D Mo, Q Jiang, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 16, 2024
[Clinical analysis of allogeneic hematopoietic cell transplantation in 9 patients with hematological malignancies complicated by Gilbert's syndrome]X L Zhu, J Z Wang, M Lyu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 2, 2025
[Clinical characteristics of HHV-6 infection after allogeneic hematopoietic stem cell transplantation]L Huang, T T Han, F F Wei, et al.
Zhonghua Yi Xue Za Zhi|August 25, 2025
[Clinical characteristics and outcomes of invasive mucormycosis after allogeneic hematopoietic stem cell transplantation]C Li, R Ma, Q Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 4, 2024
[Rituximab based treatment in pediatric Epsstain Bar Virus associated lymphocyte proliferative diseases after aplastic anemia with haplo-identical transplantation:a prospective single centre study]F Zhang, G H Hu, P Suo, et al.
Pageof 16